疫苗包装市场机会、成长动力、产业趋势分析及 2024 年至 2032 年预测

2023 年全球疫苗包装市场价值为18 亿美元，预计2024 年至2032 年复合年增长率为10.4%。支持。对先进包装解决方案的需求不断增长，以确保疫苗的安全性、有效性以及遵守严格的监管标准。具有监控功能的智慧包装等技术进步进一步提高了疫苗在储存和分销过程中的完整性，有助于市场扩张。市场依包装类型分为初级、二级和三级包装。

2023年，初级包装领域占据主导地位，占市场份额超过52%。这部分对于维持疫苗的稳定性和功效至关重要，因为它包括小瓶、注射器和安瓿，可保护疫苗免受污染，同时保持无菌。这对于需要特定储存条件的疫苗（例如 mRNA 疫苗）尤其重要。从材料来看，疫苗包装市场分为玻璃、塑胶、金属。

塑胶领域预计将经历强劲增长，预计复合年增长率将超过 11%，到 2032 年将达到 10 亿美元以上。它们提供了一种轻质、耐用的玻璃替代品，最大限度地降低了运输过程中破损的风险。此外，环烯烃聚合物（COP）和共聚物（COC）等先进塑胶材料具有优异的阻隔性能、耐化学性和透明度，使其成为需要冷链物流的疫苗的理想选择。单剂量包装的趋势可以减少浪费，也推动了对塑胶的需求，因为它们可以轻鬆地模製成各种形式，如预充式註射器和小瓶。

从地理上看，2023年北美将占全球疫苗包装市场的35%以上。合规性，鼓励包装解决方案的创新。随着美国继续扩大疫苗接种计划并为未来的公共卫生挑战做好准备，该公司在开发先进的包装解决方案以提高疫苗安全性和促进高效分配方面具有巨大潜力。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
  • 影响价值链的因素
  • 干扰
  • 未来展望
  • 製造商
  • 经销商
• 利润率分析
• 重要新闻和倡议
• 监管环境
• 衝击力
  • 成长动力
    • 增加全球疫苗接种倡议
    • 对生物製品和复杂疫苗的需求不断增长
    • 对可靠冷链包装的需求不断增长
    • 增加政府资金和公共卫生投资
    • 不断发展的医疗基础设施
  • 产业陷阱与挑战
    • 审批流程复杂
    • 初始投资成本高
• 成长潜力分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：依产品分类，2021-2032 年

• 主要趋势
• 小瓶
• 预充式註射器
• 瓶盖
• 安瓿
• 绝缘盒
• 其他的

第 6 章：市场估计与预测：按类型，2021-2032 年

• 主要趋势
• 初级包装
• 二次包装
• 三级包装

第 7 章：市场估计与预测：按材料划分，2021-2032 年

• 主要趋势
• 玻璃
• 塑胶
• 金属

第 8 章：市场估计与预测：按最终用途，2021-2032 年

• 主要趋势
• 疫苗生产商
• 医疗保健提供者
  • 医院
  • 诊所
  • 疫苗接种中心
• 研究机构
• 其他的

第 9 章：市场估计与预测：按地区，2021-2032 年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 俄罗斯
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• MEA
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 10 章：公司简介

• Amcor
• Aptar Group
• Aseptic
• Becton Dickinson
• Blowkings
• Corning
• CSafe
• DWK Life Sciences
• Fengchen Group
• Gerresheimer
• Nipro
• Romaco Group
• Schott
• Sealed Air
• SGD Pharma
• Shandong Province Medicinal Glass
• Stevanato Group
• UFP Technologies
• West Pharmaceutical Services

The Global Vaccine Packaging Market, valued at USD 1.8 billion in 2023, is expected to grow at a CAGR of 10.4% from 2024 to 2032. This growth is driven by increased global vaccination efforts, which are supported by governments and health organizations worldwide. The demand for advanced packaging solutions that ensure the safety, efficacy, and compliance of vaccines with stringent regulatory standards is rising. Technological advancements, such as smart packaging with monitoring capabilities, are further enhancing vaccine integrity during storage and distribution, contributing to market expansion. The market is segmented based on packaging type into primary, secondary, and tertiary packaging.

In 2023, the primary packaging segment held a dominant share, accounting for over 52% of the market. This segment is essential for maintaining vaccine stability and efficacy, as it includes vials, syringes, and ampoules that protect vaccines from contamination while preserving sterility. This is especially important for vaccines that require specific storage conditions, such as mRNA vaccines. In terms of materials, the vaccine packaging market is divided into glass, plastics, and metals.

The plastics segment is expected to experience robust growth, with a projected CAGR of over 11%, reaching more than USD 1 billion by 2032. Plastics are gaining traction in vaccine packaging due to their versatility and cost-effectiveness. They offer a lightweight, durable alternative to glass, minimizing the risk of breakage during transportation. Additionally, advanced plastic materials like cyclic olefin polymers (COP) and copolymers (COC) provide excellent barrier properties, chemical resistance, and transparency, making them ideal for vaccines requiring cold chain logistics. The trend towards single-dose packaging, which reduces waste, is also driving the demand for plastics, as they can be easily molded into various forms like prefilled syringes and vials.

Geographically, North America accounted for over 35% of the global vaccine packaging market in 2023. The U.S. market plays a crucial role in this growth due to its robust healthcare system and strict regulatory framework, particularly FDA compliance, which encourages innovation in packaging solutions. As the U.S. continues to expand its vaccination programs and prepares for future public health challenges, there is significant potential for companies to develop advanced packaging solutions that enhance vaccine safety and facilitate efficient distribution.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2021-2032

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Disruptions
  • 3.1.3 Future outlook
  • 3.1.4 Manufacturers
  • 3.1.5 Distributors
• 3.2 Profit margin analysis
• 3.3 Key news & initiatives
• 3.4 Regulatory landscape
• 3.5 Impact forces
  • 3.5.1 Growth drivers
    • 3.5.1.1 Increasing global vaccination initiatives
    • 3.5.1.2 Rising demand for biologics and complex vaccines
    • 3.5.1.3 Growing demand for reliable cold chain packaging
    • 3.5.1.4 Increased government funding and public health investments
    • 3.5.1.5 Growing healthcare infrastructure
  • 3.5.2 Industry pitfalls & challenges
    • 3.5.2.1 Complex approval processes
    • 3.5.2.2 High initial investment costs
• 3.6 Growth potential analysis
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product, 2021-2032 (USD Million)

• 5.1 Key trends
• 5.2 Vials
• 5.3 Prefillable syringes
• 5.4 Vial closures
• 5.5 Ampoules
• 5.6 Insulated boxes
• 5.7 Others

Chapter 6 Market Estimates & Forecast, By Type, 2021-2032 (USD Million)

• 6.1 Key trends
• 6.2 Primary packaging
• 6.3 Secondary packaging
• 6.4 Tertiary packaging

Chapter 7 Market Estimates & Forecast, By Material, 2021-2032 (USD Million)

• 7.1 Key trends
• 7.2 Glass
• 7.3 Plastics
• 7.4 Metals

Chapter 8 Market Estimates & Forecast, By End Use, 2021-2032 (USD Million)

• 8.1 Key trends
• 8.2 Vaccine manufacturers
• 8.3 Healthcare providers
  • 8.3.1 Hospitals
  • 8.3.2 Clinics
  • 8.3.3 Vaccination centers
• 8.4 Research institutions
• 8.5 Others

Chapter 9 Market Estimates & Forecast, By Region, 2021-2032 (USD Million)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 UK
  • 9.3.2 Germany
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Russia
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 South Korea
  • 9.4.5 Australia
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
• 9.6 MEA
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Amcor
• 10.2 Aptar Group
• 10.3 Aseptic
• 10.4 Becton Dickinson
• 10.5 Blowkings
• 10.6 Corning
• 10.7 CSafe
• 10.8 DWK Life Sciences
• 10.9 Fengchen Group
• 10.10 Gerresheimer
• 10.11 Nipro
• 10.12 Romaco Group
• 10.13 Schott
• 10.14 Sealed Air
• 10.15 SGD Pharma
• 10.16 Shandong Province Medicinal Glass
• 10.17 Stevanato Group
• 10.18 UFP Technologies
• 10.19 West Pharmaceutical Services